0001415889-15-000577.txt : 20150218 0001415889-15-000577.hdr.sgml : 20150216 20150217165523 ACCESSION NUMBER: 0001415889-15-000577 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150217 DATE AS OF CHANGE: 20150217 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FITLIFE BRANDS, INC. CENTRAL INDEX KEY: 0001374328 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-84096 FILM NUMBER: 15623885 BUSINESS ADDRESS: STREET 1: 4509 S. 143RD STREET STREET 2: SUITE 1 CITY: OMAHA STATE: NE ZIP: 68137 BUSINESS PHONE: 402-884-1894 MAIL ADDRESS: STREET 1: 4509 S. 143RD STREET STREET 2: SUITE 1 CITY: OMAHA STATE: NE ZIP: 68137 FORMER COMPANY: FORMER CONFORMED NAME: BOND LABORATORIES, INC. DATE OF NAME CHANGE: 20060831 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LISS MICHAEL S CENTRAL INDEX KEY: 0001252833 FILING VALUES: FORM TYPE: SC 13G/A SC 13G/A 1 liss13gadec312014.htm SCHEDULE 13G/A liss13gadec312014.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G/A
 
Under the Securities Exchange Act of 1934
(Amendment No. 3)*

 
FITLIFE BRANDS, INC.
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
33817P108
(CUSIP Number)
 
December 31 , 2014
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[   ] Rule 13d-1(b)
 
[ x ] Rule 13d-1(c)

[   ] Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. 
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 

 
 
CUSIP No. 33817P108
 
  (1) 
 
Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)
 
    Michael S. Liss
    
  (2)
 
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)  
(b)  
  (3)
 
SEC Use Only
 
  (4)
 
Citizenship or Place of Organization
 
    New York
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
  
(5) 
  
Sole Voting Power
 
    368,745
  
(6)
  
Shared Voting Power
 
    0
  
(7)
  
Sole Dispositive Power
 
    368,745
  
(8)
  
Shared Dispositive Power
 
    0
(9)
 
Aggregate Amount Beneficially Owned by Each Reporting Person
 
    368,745
(10)
 
Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]
 
    (See Instructions)
(11)
 
Percent of Class Represented by Amount in Row (9)
 
    4.5%
(12)
 
Type of Reporting Person (See Instructions)
 
    IN

 
 
 

 

 
Item 1.
 
(a) Name of Issuer
 
FITLIFE BRANDS, INC.
 
(b) Address of Issuer's Principal Executive Offices
 
4509 S. 143rd Street, Suite 1
Omaha, Nebraska, 68137
 
Item 2.
 
(a) Name of Person Filing
 
Michael S. Liss
 
(b) Address of Principal Business Office or, if none, Residence
 
c/o Concordia Capital Partners LLC
1221 Avenue of Americas
Suite 4200
New York, NY 10020
 
(c) Citizenship
 
New York
 
(d) Title of Class of Securities
 
Common Stock
 
(e) CUSIP Number
 
33817P108

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
(a) [   ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
 
(b) [   ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
 
(c) [   ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
 
(d) [   ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
 
(e) [   ] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
 
(f) [   ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
 
(g) [   ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
 
(h) [   ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i) [   ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
(j) [   ] Group, in accordance with §240.13d-1(b)(1)(ii)(J).
 
 
 

 

Item 4.
 
(a) Amount beneficially owned:
 
368,745.
 
(b) Percent of class:
 
4.5%. Based upon 8,198,516 shares of the Issuer's common stock, par value $0.01 per share, outstanding on November 13, 2014, as reported by the Issuer in its Quarterly Report on Form 10-Q filed on November 13, 2014.
 
(c) Number of shares as to which the person has:
 
(i) Sole power to vote or to direct the vote
 
368,745.
 
(ii) Shared power to vote or to direct the vote
 
0
 
(iii) Sole power to dispose or to direct the disposition of
 
368,745.
 
(iv) Shared power to dispose or to direct the disposition of
 
0

Item 5. Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ x ]
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
 
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
 
N/A

Item 8. Identification and Classification of Members of the Group.
 
N/A

Item 9. Notice of Dissolution of Group.
 
N/A

Item 10. Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 

 
 
SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date:   February 17, 2015
 
By:  
/s/ Michael Liss
 
Name: Michael Liss